Leishmaniasis: new approaches to disease control

被引:187
作者
Davies, CR
Kaye, P
Croft, SL
Sundar, S
机构
[1] Univ London London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1E 7HT, England
[2] Univ London London Sch Hyg & Trop Med, Dis Control & Vector Biol Unit, London WC1E 7HT, England
[3] Banaras Hindu Univ, Inst Med Sci, Dept Med, Varanasi 221005, Uttar Pradesh, India
来源
BRITISH MEDICAL JOURNAL | 2003年 / 326卷 / 7385期
关键词
D O I
10.1136/bmj.326.7385.377
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Leishmaniasis is one of the major infectious diseases affecting the poorest regions of the world, but new developments in diagnosis, treatment, and control offer some fresh hope.
引用
收藏
页码:377 / 382
页数:8
相关论文
共 58 条
[11]  
Braga M D, 1998, Rev Soc Bras Med Trop, V31, P419, DOI 10.1590/S0037-86821998000500001
[12]   Infectiousness in a cohort of Brazilian dogs: Why culling fails to control visceral leishmaniasis in areas of high transmission [J].
Courtenay, O ;
Quinnell, RJ ;
Garcez, LM ;
Shaw, JJ ;
Dye, C .
JOURNAL OF INFECTIOUS DISEASES, 2002, 186 (09) :1314-1320
[13]   A phase III trial of efficacy of the FML-vaccine against canine kala-azar in an endemic area of Brazil (Sao Goncalo do Amaranto, RN) [J].
da Silva, VO ;
Borja-Cabrera, GP ;
Pontes, NNC ;
de Souza, EP ;
Luz, KG ;
Palatnik, M ;
de Sousa, CBP .
VACCINE, 2000, 19 (9-10) :1082-1092
[14]   Deltamethrin-impregnated dog collars have a potent anti-feeding and insecticidal effect on Lutzomyia longipalpis and Lutzomyia migonei [J].
David, JR ;
Stamm, LM ;
Bezerra, HS ;
Souza, RN ;
Killick-Kendrick, R ;
Lima, JWO .
MEMORIAS DO INSTITUTO OSWALDO CRUZ, 2001, 96 (06) :839-847
[15]   Spraying houses in the Peruvian Andes with lambda-cyhalothrin protects residents against cutaneous leishmaniasis [J].
Davies, CR ;
Llanos-Cuentas, EA ;
Campos, P ;
Monge, J ;
Leon, E ;
Canales, J .
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 2000, 94 (06) :631-636
[16]   THE FALL AND RISE OF ANDEAN CUTANEOUS LEISHMANIASIS - TRANSIENT IMPACT OF THE DDT CAMPAIGN IN PERU [J].
DAVIES, CR ;
LLANOSCUENTAS, A ;
CANALES, J ;
LEON, E ;
ALVAREZ, E ;
MONGE, J ;
TOLENTINO, E ;
GOMERO, Q ;
PYKE, S ;
DYE, C .
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 1994, 88 (04) :389-393
[17]   Incidence of and risk factors for symptomatic visceral leishmaniasis among human immunodeficiency virus type 1-infected patients from Spain in the era of highly active antiretroviral therapy [J].
de la Rosa, R ;
Pineda, JA ;
Delgado, J ;
Macías, J ;
Morillas, F ;
Mira, JA ;
Sánchez-Quijano, A ;
Leal, M ;
Lissen, E .
JOURNAL OF CLINICAL MICROBIOLOGY, 2002, 40 (03) :762-767
[18]  
Desjeux P, 2001, Med Trop (Mars), V61, P187
[19]   Phase 2 trial of WR6026, an orally administered 8-aminoquinoline, in the treatment of visceral leishmaniasis caused by Leishmania chagasi [J].
Dietze, R ;
Carvalho, SFG ;
Valli, LC ;
Berman, J ;
Brewer, T ;
Milhous, W ;
Sanchez, J ;
Schuster, B ;
Grogl, M .
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2001, 65 (06) :685-689
[20]   Protective efficacy of lambdacyhalothrin-impregnated bednets against Phlebotomus orientalis, the vector of visceral leishmaniasis in Sudan [J].
Elnaiem, DA ;
Elnahas, AM ;
Aboud, MA .
MEDICAL AND VETERINARY ENTOMOLOGY, 1999, 13 (03) :310-314